# Comparison Between Intraligamentary Piroxicam and Articaine

> **NCT03612323** · EARLY_PHASE1 · UNKNOWN · sponsor: **Cairo University** · enrollment: 20 (estimated)

## Conditions studied

- Pulpitis - Irreversible

## Interventions

- **DRUG:** Intra-ligamentary Piroxicam
- **DRUG:** Intra-ligamentary Articaine

## Key facts

- **NCT ID:** NCT03612323
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-11
- **Primary completion:** 2019-05
- **Final completion:** 2019-08
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2018-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03612323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03612323, "Comparison Between Intraligamentary Piroxicam and Articaine". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03612323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*